Objective:

To systematically summarize the associations between lipid components within the normal range and the risk of major metabolic and endocrine diseases, with a strong emphasis on dose-response relationships and their underlying mechanisms.

Approach:

Key Findings:

• Even within the normal lipid range, variations can influence disease risk, particularly in conditions like diabetes and cardiovascular diseases.
• Traditional binary health-disease distinctions may overlook continuous dose-response patterns, complicating risk assessments.
• Subtle lipid fluctuations can induce early pathological processes such as atherosclerosis and insulin resistance, emphasizing the need for continuous monitoring.

Interpretation:

The findings suggest that normal lipid levels may not adequately reflect an individual's metabolic risk, indicating a need for refined risk assessment strategies that incorporate continuous monitoring and individualized approaches.

Limitations:

• The review may not encompass all metabolic and endocrine disorders, potentially limiting its applicability.
• Variability in individual physiological characteristics and environmental factors complicates the interpretation of lipid levels, and potential biases in the reviewed studies should be acknowledged.

Conclusion:

Future research should focus on understanding dose-response relationships in lipid management to enhance early disease identification and individualized risk management, particularly in high-risk populations.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.